glioma tissues; traumatic brain tissue samples; normal tissues; resected tumor tissues
A172; T98G; LN229; LN18; LN382; CAS1; DBTRG; NHA
cell line-derived xenograft
proliferation (promotes); cell cycle (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); glycolysis (promotes); metastasis (promotes); ceRNA regulation (promotes)
RNase R Treatment; RT-qPCR; Clinical Sample Validation; Transfection; MTT; Colony Formation Assay; Cell Cycle Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; Bioinformatics Analysis; Luciferase Reporter Assay; RNA Pull-Down; RIP (RNA Immunoprecipitation); In Vivo Animal Model
CircSEPT9 is highly expressed in glioma tissues and may provide new potential therapeutic targets for glioma.
CircSEPT9 (hsa_circ_0005320) is up-regulated in glioma tissues and cell lines. It functions as an oncogenic circRNA by sponging miR-432-5p and thereby increasing LASP1 expression, promoting proliferation, migration, invasion, glycolysis, cell cycle progression, and xenograft tumor growth while inhibiting apoptosis.
0.7795
CircRNA SEPT9 contributes to malignant behaviors of glioma cells via miR-432-5p-mediated regulation of LASP1.
combined biological and clinical study